Isis Pharmaceuticals, Inc.
|Isis Pharmaceuticals, Inc. Patent applications|
|Patent application number||Title||Published|
|20150252367||MODULATION OF TRANSTHYRETIN EXPRESSION - Provided herein are methods, compounds, and compositions for reducing expression of transthyretin mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate transthyretin amyloidosis, or a symptom thereof.||09-10-2015|
Patent applications by Isis Pharmaceuticals, Inc.